Comprehensive medication guide to Ozempic including estimated pricing, availability information, side effects, and how to find it in stock at your local pharmacy.
Estimated Insurance Pricing
$25–$150/month with prior authorization; NovoCare card can reduce to $25/month.
Estimated Cash Pricing
$800–$1,100/month retail; NovoCare savings card $349/month for uninsured.
Medfinder Findability Score
72/100
Summarize with AI
On this page
Ozempic (semaglutide) is a GLP-1 receptor agonist manufactured by Novo Nordisk. It is FDA-approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It is also approved for the reduction of risk of major adverse cardiovascular events (cardiovascular death, nonfatal heart attack, nonfatal stroke) in adults with type 2 diabetes and established cardiovascular disease.
Ozempic is administered as a once-weekly subcutaneous injection in the abdomen, thigh, or upper arm. It is not approved for weight loss (that indication belongs to Wegovy, which contains the same active ingredient at a higher dose), though it is widely used off-label for that purpose.
![How to Find a Doctor Who Can Prescribe Ozempic Near You [2026 Guide]](/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2Fvur4atr4%2Fproduction%2Ff3c55ffc9ebd0406f0ad4fc8631bd09015c1f0d5-1024x1024.png%3Frect%3D0%2C256%2C1024%2C512%26w%3D400%26h%3D200%26auto%3Dformat&w=828&q=75)
![Why Is Ozempic (Pen) So Hard to Find? [Explained for 2026]](/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2Fvur4atr4%2Fproduction%2F3a2c6f5d86c738babb25ad57ce4bb93c7a973c6e-1024x1024.png%3Frect%3D0%2C256%2C1024%2C512%26w%3D400%26h%3D200%26auto%3Dformat&w=828&q=75)
![Why Is Ozempic So Hard to Find? [Explained for 2026]](/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2Fvur4atr4%2Fproduction%2Fdb935709b48c9129392b28b07a1ab00d2b0c56eb-1024x1024.png%3Frect%3D0%2C256%2C1024%2C512%26w%3D400%26h%3D200%26auto%3Dformat&w=828&q=75)
We have a 99% success rate finding medications, even during nationwide shortages.
Need this medication?
Semaglutide mimics the naturally occurring hormone GLP-1 (glucagon-like peptide-1), which is released after eating. It works through several mechanisms:
These combined effects lead to improved blood sugar control and, in many patients, significant weight loss.
0.25 mg weekly
Starting dose for the first 4 weeks
0.5 mg weekly
First maintenance dose
1 mg weekly
Higher maintenance dose if additional glycemic control is needed
2 mg weekly
Maximum dose for patients needing further A1C reduction
As of 2026, Ozempic is generally available at most pharmacies. The FDA officially removed semaglutide from the drug shortage list on February 21, 2025, after a nearly 3-year shortage driven by unprecedented demand for off-label weight loss use. While supply has stabilized, some patients may still encounter occasional stock issues at specific pharmacies due to continued high demand. Using a tool like Medfinder can help you quickly locate pharmacies with Ozempic in stock near you.
Ozempic can be prescribed by a variety of healthcare providers, including:
Ozempic is also available through telehealth platforms, making it easier to get a prescription without an in-person visit. Use Medfinder to find providers near you who prescribe Ozempic.
No. Ozempic is not a controlled substance and has no DEA scheduling. It does not carry a risk of abuse or dependence. However, it does require a prescription from a licensed healthcare provider.
Most GI side effects are most common during dose escalation and tend to improve over time. Serious but rare side effects include pancreatitis, gallbladder problems, and diabetic retinopathy complications. Ozempic carries a boxed warning about thyroid C-cell tumors observed in rodent studies.
Know what you need? Skip the search.
Mounjaro (tirzepatide)
A dual GIP/GLP-1 receptor agonist by Eli Lilly. FDA-approved for type 2 diabetes. Weekly injection with studies showing up to 2.4% A1C reduction and up to 22.5% body weight loss at the highest dose.
Wegovy (semaglutide 2.4 mg)
Same active ingredient as Ozempic but FDA-approved specifically for chronic weight management at a higher dose. Also approved for cardiovascular risk reduction in adults with obesity.
Trulicity (dulaglutide)
A GLP-1 receptor agonist by Eli Lilly. Weekly injection for type 2 diabetes. Generally considered less potent for weight loss but has proven cardiovascular benefits.
Rybelsus (oral semaglutide)
Oral tablet form of semaglutide for type 2 diabetes. Taken daily on an empty stomach. Available in 3 mg, 7 mg, and 14 mg tablets.
Prefer Ozempic? We can find it.
Insulin and sulfonylureas
moderateIncreased risk of hypoglycemia; dose reduction of insulin or sulfonylurea may be needed when starting Ozempic
Oral contraceptives
moderateDelayed gastric emptying may reduce absorption; consider non-oral contraceptive methods or barrier backup
Warfarin and oral anticoagulants
moderateMonitor INR more frequently when initiating or changing Ozempic dose
Levothyroxine
moderateMonitor thyroid function as absorption may be affected
Oral medications in general
moderateOzempic delays gastric emptying and may impact absorption of concomitantly administered oral medications
Ozempic remains one of the most effective and widely prescribed GLP-1 receptor agonists for type 2 diabetes. After a nearly 3-year shortage that ended in early 2025, supply has largely normalized, though the medication's popularity means occasional stock issues may persist. With no generic available, cost remains a significant barrier — but manufacturer savings programs, insurance coverage, and patient assistance programs can dramatically reduce out-of-pocket expenses.
If you're having trouble finding Ozempic at your pharmacy, Medfinder can help you locate pharmacies with it in stock near you today.
Medfinder Editorial Standards
Our medication guides are researched and written to help patients make informed decisions. All content is reviewed for accuracy and updated regularly. Learn more about our standards
ChatGPT
Claude
Perplexity
Grok
Gemini